Abstract
Non-cultured melanocyte-keratinocyte transplantation combined with narrowband ultraviolet B (NB-UVB) therapy is a promising and well-tolerated treatment for facial hypo-pigmentation following scarring. This approach has shown significant improvement in patients who have not responded to other therapies.